Design, synthesis and biological evaluation of some novel 3-cinnamoyl-4-hydroxy-2H-chromen-2-ones as antimalarial agents

Medicinal Chemistry Research

Volumn 21, Issue 8, 2012, Pages 1780-1784

  Patel, Kuldeep ^a   Karthikeyan, Chandrabose ^a   Hari Narayana Moorthy, N S ^a,b   Deora, Girdhar Singh ^a   Solomon, Viswas Raja ^c,d   Lee, Hoyun ^c,d   Trivedi, Piyush ^a  

^a UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

^b UNIVERSITY OF PORTO   (Portugal)

^c Regional Hospital   (Canada)

^d LAURENTIAN UNIVERSITY   (Canada)

Author keywords

Antimalarial; Chalcones; Coumarin

Indexed keywords

3 CINNAMOYL 4 HYDROXY 2H CHROMEN 2 ONE; ANTIMALARIAL AGENT; CHLOROQUINE; UNCLASSIFIED DRUG;

ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; STRUCTURE ACTIVITY RELATION;

EID: 84866054168     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9694-1     Document Type: Article

References (32)

1. Araico A, Terencio MC, Alcaraz MJ, Dominguez JN, Leon C, Ferrandiz ML (2006) Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase. Life Sci 78:2911-2918
2. Begum NA, Roy N, Laskar RA, Roy K (2011) Mosquito larvicidal studies of some chalcone analogues and their derived products: structure-activity relationship analysis. Med Chem Res 20: 184-191
3. Boeck P, Bandeira Falcão CA, Leal PC, Yunes RA, Filho VC, Torres-Santos EC, Rossi-Bergmann B (2006) Synthesis of chalcone analogues with increased antileishmanial activity. Bioorg Med Chem 14:1538-1545
4. Chimenti F, Fioravanti R, Bolasco A, Chimenti P, Secci D, Rossi R, Yanez M, Orallo F, Ortuso F, Alcaro S (2009) Chalcones: a valid scaffold for monoamine oxidases inhibitors. J Med Chem 52:2818-2824
5. Dominguez J (2002) Chemotherapeutic agents against malaria: what next after chloroquine. Curr Top Med Chem 2:1173-1185
6. Dominguez JN, Charris JE, Lobo G, de Dominguez NG, Moreno MM, Riggione F, Sanchez E, Olson J, Rosenthal PJ (2001) Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity. Eur J Med Chem 36:555-560
7. Dominguez JN, Leon C, Rodrigues J, de Dominguez NG, Gut J, Rosenthal PJ (2005a) Synthesis and antimalarial activity of sulfonamide chalcone derivatives. Il Farmaco 60:307-311
8. Dominguez JN, Leon C, Rodrigues J, de Dominguez GN, Gut J, Rosenthal PJ (2005b) Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives. J Med Chem 48:3654-3658
9. Frolich S, Schubert C, Bienzle U, Jenett-Siems K (2005) In vitro antiplasmodial activity of prenylated chalcone derivatives of hops (Humulus lupulus) and their interaction with haemin. J Antimicrob Chemother 55:883-887
10. Geyer JA, Keenan SM, Woodard CL, Thompson PA, Gerena L, Nichols DA, Gutteridge CE, Waters NC (2009) Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenones. Bioorg Med Chem Lett 19:1982-1985
11. Go ML, Liu M, Wilairat P, Rosenthal PJ, Saliba KJ, Kirk K (2004) Antiplasmodial chalcones inhibit sorbitol-induced hemolysis of Plasmodium falciparum-infected erythrocytes. Antimicrob Agents Chemother 48:3241-3245
12. Go ML, Wu X, Liu XL (2005) Chalcones: an update on cytotoxic and hemoprotective properties. Curr Med Chem 12:481-499
13. Guerin P, Olliaro P, Nosten F, Druilhe P, Laxminarayan R, Binka F, Kilama W, Ford N, White N (2002) Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis 2:564-573
14. Huang F, Tang LH, Yu L, Ni YC, Wang QM, Nan FJ (2006) In vitro potentiation of antimalarial activities by Daphnetin derivatives against Plasmodium falciparum. Biomed Environ Sci 19:367-370
15. Kharazmi A, Chen M, Theander T, Christensen SB (1997) Chloroquine resistance in Pakistan and the upsurge of falciparum malaria in Pakistani and Afghan refugee populations. Ann Trop Med Parasitol 91:591-602
16. Macreadie I, Ginsburg H, Sirawaraporn W, Tilley L (2000) Antimalarial drug development and new targets. Parasitol Today 16: 438-444
17. Narender R, Reddy PK (2007) A simple and highly efficient method for the synthesis of chalcones by using borontrifluoride-etherate. Tetrahedron Lett 48:3177-3180
18. Neekhara R, Mishra BJ, Moorthy NSHN (2006a) QSAR studies of antimalarial agents: 2,4-diamino pyrimidine derivatives. Asian J Chem 18(2):1167-1173
19. Neekhara R, Mishra BJ, Moorthy NSHN (2006b) Dihydrofolate reductase enzymes in malaria parasites: a potent target for novel antimalarial research. Asian J Cell Biol 2:48-58
20. Nivsarkar M, Thavaselvam D, Prasanna S, Sharma M, Kaushik MP (2005) Design, synthesis and biological evaluation of novel bicyclic b-lactams as potential antimalarials. Bioorg Med Chem Lett 15:1371-1373
21. Patel K, Karthikeyan C, Solomon VR, Moorthy NSHN, Lee H, Sahu K, Deora GS, Trivedi P (2011) Synthesis of some coumarinyl chalcones and their antiproliferative activity against breast cancer cell lines. Lett Drug Des Dis 8:308-311
22. Sahu NK, Sahu S, Kohli DV (2008) Novel molecular targets for antimalarial drug development. Chem Biol Drug Des 71: 287-297
23. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112
24. Solomon VR, Hu C, Lee H (2009) Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity. Bioorg Med Chem 17:7585-7592
25. Sun Y-F, Cui Y-P (2008) The synthesis, characterization and properties of coumarin-based chromophores containing a chalcone moiety. Dyes Pigments 78:65-76
26. Tomar V, Bhattacharjee G, Kamaluddin, Rajakumar S, Srivastava K, Puri SK (2010) Synthesis of new chalcone derivatives containing acridinyl moiety with potential antimalarial activity. Eur J Med Chem 45:745-751
27. Trager W, Jensen JB (1976) Human malaria parasites in continuous culture. Science 193:673-675
28. Vichai V, Kirtikara K (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1:1112-1116
29. Wu X, Wilairat P, Go ML (2002) Antimalarial activity of ferrocenyl chalcones. Bioorg Med Chem Lett 12:2299-2302
30. Wu X, Tiekink ERT, Kostetski I, Kocherginsky N, Tan ALC, Khoo SB, Wilairat P, Go ML (2006) Antiplasmodial activity of ferrocenyl chalcones: investigations into the role of ferrocene. Eur J Pharm Sci 27:175-187
31. Yang YZ, Ranz A, Pan HZ, Zhang ZN, Lin XB, Meshnick SR (1992) Daphnetin: a novel antimalarial agent with in vitro and in vivo activity. Am J Trop Med Hyg 46:15-20
32. Ziegler HL, Hansen HS, Staerk D, Christensen SB, Hagerstrand H, Jaroszewski JW(2004) The antiparasitic compound licochalconeA is a potent echinocytogenic agent that modifies the erythrocyte membrane in the concentration range where antiplasmodial activity is observed. Antimicrob Agents Chemother 48:4067-4071